107 related articles for article (PubMed ID: 2016687)
21. Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus.
Ruan KS; Lilly F
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12202-6. PubMed ID: 1465459
[TBL] [Abstract][Full Text] [Related]
22. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
[TBL] [Abstract][Full Text] [Related]
23. Effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) on Friend leukemia virus infections in mice.
Sidwell RW; Allen LB; Huffman JH; Witkowski JT; Sinon LN
Proc Soc Exp Biol Med; 1975 Mar; 148(3):854-8. PubMed ID: 1129309
[TBL] [Abstract][Full Text] [Related]
24. The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus).
Strestik BD; Olbrich ARM; Hasenkrug KJ; Dittmer U
J Gen Virol; 2001 Jun; 82(Pt 6):1349-1354. PubMed ID: 11369878
[TBL] [Abstract][Full Text] [Related]
25. Murine models for antiretroviral therapy.
Ruprecht RM
Intervirology; 1989; 30 Suppl 1():2-11. PubMed ID: 2540110
[TBL] [Abstract][Full Text] [Related]
26. Different immunological requirements for protection against acute versus persistent Friend retrovirus infections.
Dittmer U; Hasenkrug KJ
Virology; 2000 Jun; 272(1):177-82. PubMed ID: 10873760
[TBL] [Abstract][Full Text] [Related]
27. Antibody-induced modulation of Friend virus cell surface antigens decreases virus production by persistent erythroleukemia cells: influence of the Rfv-3 gene.
Chesebro B; Wehrly K; Doig D; Nishio J
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5784-8. PubMed ID: 293683
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of mortality and induction of immunity to Friend disease by lectin-treated virus.
Dent PB
J Natl Cancer Inst; 1973 Feb; 50(2):511-3. PubMed ID: 4702122
[No Abstract] [Full Text] [Related]
29. Effects of tacrolimus on infection of Friend murine leukemia virus to Fv-4 gene heterozygous mice.
Zhang FM; Yang BF; Gu HX; Chen XB; Zhong ZH; Cheng Z
Acta Pharmacol Sin; 2004 Feb; 25(2):208-12. PubMed ID: 14769211
[TBL] [Abstract][Full Text] [Related]
30. Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats.
Hayes KA; Wilkinson JG; Frick R; Francke S; Mathes LE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jun; 9(2):114-22. PubMed ID: 7749786
[TBL] [Abstract][Full Text] [Related]
31. Studies on the role of the host immune response in recovery from Friend virus leukemia. I. Antiviral and antileukemia cell antibodies.
Chesebro B; Wehrly K
J Exp Med; 1976 Jan; 143(1):73-84. PubMed ID: 1244422
[TBL] [Abstract][Full Text] [Related]
32. Augmentation of helper virus replication in the presence of defective retrovirus.
Anand R; Steeves RA; Lilly F
Microbios; 1989; 58(235):71-82. PubMed ID: 2544787
[TBL] [Abstract][Full Text] [Related]
33. Friend erythroleukemia antigen. A viral antigen specified by spleen focus-forming virus and differentiation antigen controlled by the Fv-2 locus.
Risser R
J Exp Med; 1979 May; 149(5):1152-67. PubMed ID: 448285
[TBL] [Abstract][Full Text] [Related]
34. Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases.
Lai MH; Tang J; Wroblewski V; Dee AG; Margolin N; Vlahos C; Bowdon B; Buckheit R; Colacino J; Hui KY
J Acquir Immune Defic Syndr (1988); 1993 Jan; 6(1):24-31. PubMed ID: 8093263
[TBL] [Abstract][Full Text] [Related]
35. Shut-down of virus synthesis during progression of erythroleukemia induced by Friend virus in mice.
Yoosook C
Int J Cancer; 1982 Jun; 29(6):659-65. PubMed ID: 6955290
[TBL] [Abstract][Full Text] [Related]
36. Elucidation of mode of retroviral-inhibitory effects of imexon through use of immune competent and severe combined immune deficiency (SCID) mice.
Morrey JD; Mead JR; Warren RP; Okleberry KM; Burger RA; Sidwell RW
Antiviral Res; 1992 Mar; 17(3):223-33. PubMed ID: 1314537
[TBL] [Abstract][Full Text] [Related]
37. Murine retroviral disease-enhancing effects of a pyrimidinone immunomodulator.
Warren RP; Morrey JD; Burger RA; Okleberry KM; Sidwell RW
Antiviral Res; 1992 Sep; 19(3):233-45. PubMed ID: 1444328
[TBL] [Abstract][Full Text] [Related]
38. Temporal effects of gamma interferon deficiency on the course of Friend retrovirus infection in mice.
Stromnes IM; Dittmer U; Schumacher TN; Schepers K; Messer RJ; Evans LH; Peterson KE; Race B; Hasenkrug KJ
J Virol; 2002 Mar; 76(5):2225-32. PubMed ID: 11836400
[TBL] [Abstract][Full Text] [Related]
39. [Effect of exogenous and endogenous interferons on the course of leukemia induced by Friend virus in mice].
Sadashvili MK; Furer NM
Antibiotiki; 1970 Jan; 15(1):52-5. PubMed ID: 4909951
[No Abstract] [Full Text] [Related]
40. Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
Takamura S; Tsuji-Kawahara S; Yagita H; Akiba H; Sakamoto M; Chikaishi T; Kato M; Miyazawa M
J Immunol; 2010 May; 184(9):4696-707. PubMed ID: 20351188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
